Cartesian Therapeutics
RNAC
RNAC
36 hedge funds and large institutions have $32.4M invested in Cartesian Therapeutics in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
56% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 16
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Holders
36
Holding in Top 10
1
Calls
$53K
Puts
–
Top Buyers
| 1 | +$285K | |
| 2 | +$44.7K | |
| 3 | +$23K | |
| 4 |
Two Sigma Investments
New York
|
+$20K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$15.9K |
Top Sellers
| 1 | -$977K | |
| 2 | -$824K | |
| 3 | -$758K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$524K |
| 5 |
Millennium Management
New York
|
-$253K |